World Immunization Week - Emerging Infectious Disease journal - CDC

World Immunization Week - Emerging Infectious Disease journal - CDC

World Immunization Week

National Infant Immunization Week, set for April 24 – April 28, 2017, is an annual observance to highlight the importance of protecting against vaccine-preventable diseases. 

Immunization is one of the most successful and cost-effective health interventions, preventing millions of deaths every year. From infants to seniors, immunization protects against diseases such as diphtheria, measles, pertussis (whooping cough), pneumonia, polio, rotavirus, rubella and tetanus. The benefits of immunization are increasingly being extended to adolescents and adults, providing protection against life-threatening diseases such as influenza, meningitis, and cancers (cervical and liver cancers).

Click on these links to Emerging Infectious Diseases articles and podcasts below and learn more about the latest information on vaccine-preventable diseases.

Articles

Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016
H. Campbell et al. (Volume 23, Number 7)

Rise in Group W Meningococcal Carriage in University Students, United Kingdom
N. J. Oldfield et al. (Volume 23, Number 6)

Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States
C. P. Andam et al. (Volume 23, Number 6)

Clinical and Molecular Characteristics of Human Rotavirus G8P[8] Outbreak Strain, Japan, 2014
K. Kondo et al. (Volume 23, Number 6)

Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection
M. H. Collins et al. (Volume 23, Number 5)

Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016
H. M. Soeters et al. (Volume 23, Number 5)

Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China
F. Cui et al. (Volume 23, Number 5)

Biologic Evidence Required for Zika Disease Enhancement by Dengue Antibodies
S. B. Halstead (Volume 23, Number 4)

Neurologic Complications of Influenza B Virus Infection in Adults, Romania
C. P. Popescu et al. (Volume 23, Number 4)

Epidemiology of Invasive Haemophilus influenzae Disease, Europe, 2007–2014
R. Whittaker et al. (Volume 23, Number 3)

Serologic Evidence for MERS-CoV Infection in Dromedary Camels, Punjab, Pakistan, 2012–2015
M. Saqib et al. (Volume 23, Number 3)

Cerebrospinal Fluid Findings in an Adult with Human Metapneumovirus–Associated Encephalitis
N. Jeannet et al. (Volume 23, Number 2)

Correlation of West Nile Virus Incidence in Donated Blood with West Nile Neuroinvasive Disease Rates, United States, 2010–2012
E. Betsem et al. (Volume 23, Number 2)

Changing Epidemiology of Hepatitis A and Hepatitis E Viruses in China, 1990–2014
X. Ren et al. (Volume 23, Number 2)

Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014–April 2016
G. Shirreff et al. (Volume 23, Number 2)

Human Tick-Borne Encephalitis, the Netherlands
V. Hira and B. Rockx (Volume 23, Number 1)

Increased Invasive Pneumococcal Disease, North East England, UK
C. Houseman et al. (Volume 23, Number 1)

Haemophilus influenzae Type b Invasive Disease in Amish Children, Missouri, USA, 2014
A. L. Myers et al. (Volume 23, Number 1)

Acute Respiratory Disease in US Army Trainees 3 Years after Reintroduction of Adenovirus Vaccine
N. S. Clemmons et al. (Volume 23, Number 1)

Oral Cholera Vaccine Coverage during an Outbreak and Humanitarian Crisis, Iraq, 2015
E. Lam et al. (Volume 23, Number 1)

Time Course of MERS-CoV Infection and Immunity in Dromedary Camels
B. Meyer et al. (Volume 22, Number 12)

African Horse Sickness Caused by Genome Reassortment and Reversion to Virulence of Live, Attenuated Vaccine Viruses, South Africa, 2004–2014
C. T. Weyer et al. (Volume 22, Number 12)

Anomalous High Rainfall and Soil Saturation as Combined Risk Indicator of Rift Valley Fever Outbreaks, South Africa, 2008–2011
R. Williams et al. (Volume 22, Number 12)

Neutralizing Antibodies to Severe Fever with Thrombocytopenia Syndrome Virus 4 Years after Hospitalization, China
Y. Huang et al. (Volume 22, Number 11)

Meningococcal Disease in US Military Personnel before and after Adoption of Conjugate Vaccine
M. D. Decker (Volume 22, Number 11)

Dog-Mediated Human Rabies Death, Haiti, 2016
R. M. Wallace et al. (Volume 22, Number 11)

Reemergence of Japanese Encephalitis in South Korea, 2010–2015
J. Sunwoo et al. (Volume 22, Number 10)

Yellow Fever—More a Policy and Planning Problem than a Biological One
C. H. Calisher and J. P. Woodall (Volume 22, Number 10)

Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes
D. Mesher et al. (Volume 22, Number 10)

Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995–2014
M. Shaghaghi et al. (Volume 22, Number 10)

Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia
Y. M. Arabi et al. (Volume 22, Number 9)

Toward Developing a Preventive MERS-CoV Vaccine—Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14–15, 2015
J. Excler et al. (Volume 22, Number 8)

Meningococcal Group W Disease in Infants and Potential Prevention by Vaccination
S. R. Parikh et al. (Volume 22, Number 8)

Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus
T. M. Uyeki et al. (Volume 22, Number 7)

Yellow Fever in a Worker Returning to China from Angola, March 2016
Y. Ling et al. (Volume 22, Number 7)

Postbooster Antibodies from Humans as Source of Diphtheria Antitoxin
J. F. Bermejo-Martin et al. (Volume 22, Number 7)

Interferon-γ Autoantibodies as Predisposing Factor for Nontuberculous Mycobacterial Infection
F. Valour et al. (Volume 22, Number 6)

MERS-CoV Antibodies in Humans, Africa, 2013–2014
A. M. Liljander et al. (Volume 22, Number 6)

Ecologic Study of Meningococcal B Vaccine and Neisseria gonorrhoeae Infection, Norway
J. Whelan et al. (Volume 22, Number 6)

Population-Level Effect of Cholera Vaccine on Displaced Populations, South Sudan, 2014
A. S. Azman et al. (Volume 22, Number 6)

Changes in Childhood Pneumonia Hospitalizations by Race and Sex Associated with Pneumococcal Conjugate Vaccines
A. D. Wiese et al. (Volume 22, Number 6)

Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome Coronavirus
G. Crameri et al. (Volume 22, Number 6)

Post-Ebola Measles Outbreak in Lola, Guinea, January–June 2015
J. E. Suk et al. (Volume 22, Number 6)

Crimean-Congo Hemorrhagic Fever Virus IgG in Goats, Bhutan
S. Wangchuk et al. (Volume 22, Number 5)

Suspected Rabies in Humans and Animals, Laikipia County, Kenya
M. Obonyo et al. (Volume 22, Number 3)

Avian Influenza A(H5N1) Virus in Egypt
G. Kayali et al. (Volume 22, Number 3)

Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England
S. Ladhani et al. (Volume 22, Number 2)

Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003–2013
C. von Mollendorf et al. (Volume 22, Number 2)

Sustained Transmission of Pertussis in Vaccinated, 1–5-Year-Old Children in a Preschool, Florida, USA
J. Matthias et al. (Volume 22, Number 2)

Hemagglutinin Gene Clade 3C.2a Influenza A(H3N2) Viruses, Alachua County, Florida, USA, 2014–15
J. Lednicky et al. (Volume 22, Number 1)

Effectiveness of Ring Vaccination as Control Strategy for Ebola Virus Disease
A. J. Kucharski et al. (Volume 22, Number 1)

Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior
I. Baussano et al. (Volume 22, Number 1)

Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009–2013
R. L. Cameron et al. (Volume 22, Number 1)

Carriage Rate and Effects of Vaccination after Outbreaks of Serogroup C Meningococcal Disease, Brazil, 2010

Schmallenberg Virus Antibodies in Adult Cows and Maternal Antibodies in Calves

Efficiency of Points of Dispensing for Influenza A(H1N1)pdm09 Vaccination, Los Angeles County, California, USA, 2009

Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012

Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia

Distribution of Pandemic Influenza Vaccine and Reporting of Doses Administered, New York, New York, USA

Regional Variation in Travel-related Illness acquired in Africa, March 1997–May 2011

Etymologia: Pertactin

Hendra Virus Vaccine, a One Health Approach to Protecting Horse, Human, and Environmental Health

Neisseria meningitidis Serogroup W, Burkina Faso, 2012

Special Considerations for Prophylaxis for and Treatment of Anthrax in Pregnant and Postpartum Women

Seven-Valent Pneumococcal Conjugate Vaccine and Nasopharyngeal Microbiota in Healthy Children

Resolution of Novel Human Papillomavirus–induced Warts after HPV Vaccination

Dynamic Modeling of Cost-effectiveness of Rotavirus Vaccination, Kazakhstan

Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009

Pseudorabies Virus Variant in Bartha-K61–Vaccinated Pigs, China, 2012

Evidence of Vaccine-related Reassortment of Rotavirus, Brazil, 2008–2010

Clinical Profile of Children with Norovirus Disease in Rotavirus Vaccine Era

Emergence of Vaccine-derived Polioviruses, Democratic Republic of Congo, 2004–2011

Ongoing Measles Outbreak in Orthodox Jewish Community, London, UK

Mumps Postexposure Prophylaxis with a Third Dose of Measles-Mumps-Rubella Vaccine, Orange County, New York, USA

Call to Action for Dengue Vaccine Failure

Detection of Novel Rotavirus Strain by Vaccine Postlicensure Surveillance

Duration of Immunity to Norovirus Gastroenteritis

Influence of Pneumococcal Vaccines and Respiratory Syncytial Virus on Alveolar Pneumonia, Israel

Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999–2011

Wild Poliovirus Importation, Central African Republic

Reemergence of Recombinant Vaccine–derived Polioviruses in Healthy Children, Madagascar

In Memoriam: Alexander I. Klimov (1943–2013)

Changes in Severity of Influenza A(H1N1)pdm09 Infection from Pandemic to First Postpandemic Season, Germany

Risk Factors for Influenza among Health Care Workers during 2009 Pandemic, Toronto, Ontario, Canada

Pale horse, pale rider done taken my lover away

Effect of 10-Valent Pneumococcal Vaccine on Pneumonia among Children, Brazil

Myth Dispelled

Measles Elimination Efforts and 2008–2011 Outbreak, France

Virulence of Pertactin-Negative Bordetella pertussis Isolates from Infants, France

Effects of Vaccine Program against Pandemic Influenza A(H1N1) Virus, United States, 2009–2010

Lessons and Challenges for Measles Control from Unexpected Large Outbreak, Malawi

Rinderpest Virus Sequestration and Use in Posteradication Era

Hepatitis E, a Vaccine-Preventable Cause of Maternal Deaths

Podcasts

Outbreak of a New Strain of Flu at a Fair

Flu-related Hospitalizations by Industry

Pneumococcal Pneumonia and Pandemic H1N1

Invasive Meningococcal Men Y Disease

Additional Resources

Centers for Disease Control and Prevention

World Health Organization